Vitae Pharmaceuticals Inc., an Allergan affiliate

Pharma

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Orange Book Patents

Across 1 drug with upcoming expirations

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Patent Expirations

2 patent groups across drugs · Source: FDA Orange Book

DrugExpires

ActonelJan 16, 2026 Actonel2 patentsJan 9, 2028

Regulatory

Regulatory Timeline

19823 events

FDAJan 1

Didronel — DIDRONEL

Application NDA017831 (NDA)

FDAJan 1

Ophthaine — OPHTHAINE

Application NDA008883 (NDA)

FDAJan 1

Ophthaine — OPHTHETIC

Application NDA012583 (NDA)

19871 event

FDAApr 20

Didronel — DIDRONEL

Application NDA019545 (NDA)

19912 events

FDADec 9

Botox — BOTOX COSMETIC

Application BLA103000 (BLA)

FDAApr 24

Prozac — PROZAC

Application NDA020101 (NDA)

19921 event

FDADec 23

Prozac — PROZAC

Application NDA018936 (NDA)

19991 event

FDAMar 9

Prozac — PROZAC

Application NDA020974 (NDA)

20001 event

FDAApr 14

Actonel — ACTONEL

Application NDA020835 (NDA)

20011 event

FDAFeb 26

Prozac — PROZAC WEEKLY

Application NDA021235 (NDA)

20031 event

FDAOct 16

Elestat — ELESTAT

Application NDA021565 (NDA)

20041 event

FDAMay 28

Sanctura Xr — SANCTURA

Application NDA021595 (NDA)

20061 event

FDAMay 19

Prozac — SARAFEM

Application NDA021860 (NDA)

20072 events

FDADec 17

Bystolic — BYSTOLIC

Application NDA021742 (NDA)

FDAAug 3

Sanctura Xr — SANCTURA XR

Application NDA022103 (NDA)

20101 event

FDAOct 8

Actonel — ATELVIA

Application NDA022560 (NDA)

20111 event

FDAOct 6

Prozac — FLUOXETINE HYDROCHLORIDE

Application NDA202133 (NDA)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)